International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8419033
Original Article
Study of Factors Affecting For Non Adherence to Medications in Elderly Hypertensives in a Tertiary Care Hospital
 ,
 ,
Published
Oct. 7, 2023
Abstract

Introduction: The prevalence of hypertension in the elderly is increasing worldwide. Non adherence to medication in elderly is a major concern which is associated with adverse outcomes. Non adherence to medications is a complex issue hence this study is undertaken to study factors affecting for non adherence to medications in elderly hypertensive patients. Materials And Methods: This retrospective study included 270 elderly patients i.e. (>60 years) after screening among out patients visiting general medicine and geriatric departments of BMCRI, Bangalore. Complete physical examination, BP measurement and the reasons for non adherence were assessed from patients. Results: Total of 270 patients, majority were in the age group of 60-70 years (63.3%). Males and females were 60% and 40%.The duration of hypertension was more in the range of 10-15 years (36%), followed by 15-20 years in (33.3%).The common reasons for non adherence was“ the high cost” in 22% and “too many tablets to consume” in 18.7% of patients. Remaining 16% “did not understand the importance” in taking medication, about 13% of due to its “side effects” around 9% due to “forget fullness” and 6% stopped medications as they were “asymptomatic”.Conclusion: The problem of non-adherence to medications is universal in patients with hypertension. The main reasons are poly pharmacy and increased cost in our study. Others include poor consultation, forgetfulness in elderly patients. Regular and repeated consultation especially establishment of “hypertensive clinics” will go a long way to improve the adherence to treatment protocol in hypertension patients.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
1620 Views
459 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved